Published in Crit Care on May 23, 2014
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet (2013) 6.76
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet (1993) 5.77
Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation (1991) 4.52
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost (2010) 4.45
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med (2010) 4.01
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65
Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med (1989) 3.65
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol (2007) 3.09
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. Thromb Haemost (2010) 3.03
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation (2013) 3.02
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med (2013) 2.84
A specific antidote for dabigatran: functional and structural characterization. Blood (2013) 2.77
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost (2011) 2.75
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost (2012) 2.61
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care (2011) 2.23
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Surgical management of acute subdural hematomas. Neurosurgery (2006) 2.11
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke (1995) 2.08
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost (2012) 2.04
Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med (2003) 2.00
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med (2002) 1.95
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Surgical management of acute epidural hematomas. Neurosurgery (2006) 1.90
Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Thromb Haemost (2013) 1.83
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Intracranial hemorrhage as a complication of anticoagulant therapy. Neurology (1959) 1.71
Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology (2001) 1.69
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood (2008) 1.64
The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol (1984) 1.63
Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab (2001) 1.53
Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology (2009) 1.49
Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke (2005) 1.49
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol (1997) 1.48
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology (2011) 1.47
Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR. Circ Cardiovasc Interv (2013) 1.46
Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: yes. Stroke (2011) 1.46
Warfarin use leads to larger intracerebral hematomas. Neurology (2008) 1.43
Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery (2005) 1.43
Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost (1997) 1.41
Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity. Crit Care (2011) 1.40
Emergency assessment of hemostasis in the bleeding patient. Int J Lab Hematol (2013) 1.40
Multidisciplinary approach to the challenge of hemostasis. Anesth Analg (2009) 1.37
Warfarin reversal. J Clin Pathol (2004) 1.33
Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 1.26
Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke (2012) 1.25
The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery (1998) 1.24
Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens (2008) 1.20
Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke (2010) 1.19
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol (2001) 1.17
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation (2002) 1.13
Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma (2011) 1.11
Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke (1991) 1.11
Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res (2006) 1.11
Anticoagulant-associated intracerebral hemorrhage. Semin Neurol (2011) 1.10
Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke (2008) 1.08
Intracranial hemorrhage associated with anticoagulation therapy. Surg Neurol (1977) 1.07
Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost (2007) 1.04
Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care (2006) 1.02
The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost (1995) 1.02
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res (2007) 1.02
The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran. Int J Lab Hematol (2012) 1.01
Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology (2006) 1.01
Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study. Stroke (2004) 1.00
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis (2003) 1.00
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.99
Warfarin and intracranial haemorrhage. Blood Rev (2008) 0.99
Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol (2008) 0.98
Intracerebral hemorrhage: non-hypertensive causes. Stroke (1986) 0.96
Reversal of target-specific oral anticoagulants. J Thromb Thrombolysis (2013) 0.96
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran. Emerg Med J (2013) 0.95
Recombinant factor VIIa as an antidote for anticoagulant treatment. Semin Hematol (2004) 0.91
Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom. Clin Ther (2010) 0.89
Management and outcome of patients with acute traumatic subdural hematomas and pre-injury oral anticoagulation therapy. Neurol Res (2009) 0.88
Anticoagulant-related intracerebral hemorrhage. Neurology (1985) 0.88
Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator. Neurocrit Care (2012) 0.87
Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin. Pharmacotherapy (2006) 0.86
Stroke prevention and treatment. J Am Coll Cardiol (2010) 1.05
Cervical artery dissection: risk factors, treatment, and outcome; a 5-year experience from a tertiary care center. Int J Neurosci (2011) 0.89
In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts. Cytometry A (2011) 0.89
Endovascular management of symptomatic vertebral artery origin stenosis in the presence of an acute thrombus. J Neurointerv Surg (2011) 0.87
Reversible obstructive hydrocephalus from hypertensive encephalopathy. Neurocrit Care (2012) 0.86
Predictors of tracheostomy in patients with spontaneous intracerebral hemorrhage. Clin Neurol Neurosurg (2012) 0.84
Gluten ataxia: an important treatable etiology of sporadic ataxia. Int J Neurosci (2012) 0.82
Non-aneurysmal perimesencephalic subarachnoid hemorrhage caused by a cavernous angioma. Neurocrit Care (2011) 0.80
Basilar artery occlusion treated with mechanical thrombectomy beyond eight hours with successful recanalization and good functional outcomes. Cerebrovasc Dis (2009) 0.78
Age changes in the human oculomotor nerve - a stereological study. Ann Anat (2009) 0.78
Functional müllerian tissue within the conus medullaris generating cyclical neurological morbidity in an otherwise healthy female. Childs Nerv Syst (2013) 0.77
Year in review 2011: Critical Care--Neurocritical care. Crit Care (2012) 0.75
Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use. Muscle Nerve (2009) 0.75
Spontaneous cerebral air embolism associated with remote lung surgery. Neurocrit Care (2008) 0.75
An unusual presentation of a vein of Galen thrombosis. Acta Neurol Belg (2012) 0.75